“Expanding our range of technologies to include bioresorbable nonwovens for use in managing surgical hemostasis brings our customers several benefits: the innovative solution is more effective than existing options, so it reduces costs and can, in some cases, even save lives,” said Dr. Henk R. Randau, SVP of the global Healthcare Division at Freudenberg Performance Materials. The technology in question is used in the manufacture of nonwovens made from bioresorbable raw materials that are resorbed by the body. Freudenberg has installed specially-designed equipment for this purpose. Looking to the future, the company plans to collaborate with partners to offer a broad range of solutions for bioactive wound healing, drug release and regenerative medicine based on this technology.